Boronate Affinity Chromatography Market
Report ID: SQMIG35J2827
Report ID: SQMIG35J2827
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35J2827 |
Region:
Global |
Published Date: August, 2026
Pages:
157
|Tables:
117
|Figures:
77
Global Boronate Affinity Chromatography Market size was valued at USD 472.0 Million in 2024 and is poised to grow from USD 514.01 Million in 2025 to USD 1016.71 Million by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).
Global Boronate Affinity Chromatography market centers on a resin‑based separation technology that selectively captures cis‑diol‑containing biomolecules, most notably glycoproteins and glycoconjugates. Its primary driver is the exponential growth of biologics, particularly monoclonal antibodies, which require efficient, high‑purity purification to meet stringent regulatory standards. Historically, protein A chromatography dominated antibody purification, but increasing demand for site‑specific glyco‑engineering has shifted interest toward boronate media because it preserves native glycan structures. Since the early 2000s, vendors such as Thermo Fisher and Pall have introduced tailored resins, and the market has expanded from niche research labs to large‑scale manufacturing, illustrating its rising relevance.
The broader adoption of continuous bioprocessing acts as a pivotal catalyst because it requires robust inline purification capable of preserving product quality at high throughput. Boronate affinity columns meet this demand with rapid binding kinetics and simple regeneration, allowing seamless integration into skid‑mounted systems used for insulin analogs and viral‑vector vaccines. As manufacturers invest in automation and scale‑up of boronate technology, resin suppliers respond by developing higher‑capacity media and advanced analytics. This feedback loop expands the addressable market, eases regulatory acceptance, and invites new entrants to explore niche uses such as glycan profiling in biopharma for drug development and precision.
How is AI-driven automation influencing the growth of the boronate affinity chromatography market?
AI‑driven automation is reshaping boronate affinity chromatography by streamlining method development and reducing hands‑on time. Machine learning models predict optimal ligand‑target interactions, allowing quicker assay design and higher reproducibility. Integrated robotic platforms handle column packing, sample loading and elution with minimal human intervention, which improves throughput and lowers error rates. Real‑time data analytics guide process adjustments on the fly, ensuring consistent product quality. These advances make the technology more attractive for biopharmaceutical purification and glycan analysis, accelerating adoption across research and manufacturing labs while supporting the market’s expanding demand.
Market snapshot - (2026-2033)
Global Market Size
USD 472.0 Million
Largest Segment
Boronate Affinity Resins
Fastest Growth
Boronate Affinity Kits
Growth Rate
8.9% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global boronate affinity chromatography market is segmented by product type, application, end user, technique and region. Based on product type, the market is segmented into Boronate Affinity Resins, Boronate Affinity Columns and Boronate Affinity Kits. Based on application, the market is segmented into Glycoprotein Purification, Glycan Analysis, Biomarker Research and Drug Discovery. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations. Based on technique, the market is segmented into Analytical Chromatography and Preparative Chromatography. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Boronate affinity resins segment dominates because they provide the fundamental binding matrix that underpins most purification workflows, offering high specificity for cis‑diol groups and robust chemical stability. Their versatility across both analytical and preparative formats makes them the preferred choice for method development, while their ease of regeneration reduces operational cost, driving widespread adoption across the industry and facilitating rapid scale‑up for commercial production pipelines while maintaining consistent product quality.
However, boronate affinity columns segment is witnessing the strongest growth momentum because evolving high‑throughput screening platforms demand ready‑to‑use column formats that reduce set‑up time. Integrated packaging and improved column lifetimes attract both research and process labs, accelerating adoption and opening new opportunities for automated glycoprotein capture workflows in pharmaceutical pipelines.
Glycoprotein purification application segment dominates because it addresses the core need of isolating therapeutically relevant glycoproteins with high purity, a prerequisite for biologics development. The direct link to product efficacy and regulatory compliance fuels sustained investment, and continual advances in resin chemistry enhance selectivity, making this application the backbone of market revenue. Furthermore, the growing pipeline of biosimilar candidates requires rigorous purification, prompting companies to allocate resources toward optimized glycoprotein capture strategies and supporting service ecosystems.
On the other hand, biomarker research application segment emerges as the key high‑growth area because emerging diagnostics rely on detecting disease‑specific glycan signatures. Increased funding for early‑detection programs and the integration of glycan profiling into personalized medicine drive demand, positioning this application to expand market reach and stimulate innovative assay development.
To get detailed segments analysis, Request a Free Sample Report
The region benefits from a deep integration of world‑leading pharmaceutical firms, extensive biotech research clusters and a mature infrastructure that supports high‑end analytical technologies. Robust funding mechanisms and a regulatory climate that encourages innovation create a fertile environment for the development and adoption of advanced chromatography solutions. Strong collaborations between academic institutions, research hospitals and equipment manufacturers accelerate knowledge transfer and drive product refinement. A highly skilled workforce, combined with a culture of early technology adoption, ensures that novel affinity platforms are rapidly tested and deployed. Moreover, the presence of major instrument suppliers and service providers in close proximity to end‑users facilitates responsive support and customized solutions, reinforcing the region’s leadership.
Boronate Affinity Chromatography Market in the United States thrives on a concentration of leading biotech hubs, extensive pharmaceutical pipelines and a culture of rapid innovation. The ecosystem is bolstered by deep investment in research facilities, strong partnerships between academia and industry, and a regulatory environment that supports advanced analytical methods. This synergy enables swift translation of laboratory breakthroughs into commercial applications, reinforcing the United States as a central node for technology advancement and market expansion.
Boronate Affinity Chromatography Market in Canada is shaped by a collaborative research landscape that links universities, government laboratories and emerging biotech firms. Emphasis on sustainable drug development and a supportive funding framework encourages the exploration of novel affinity techniques. Proximity to major North American pharmaceutical corridors and a growing network of specialist service providers enhance accessibility to cutting‑edge chromatography platforms, positioning Canada as a strategic contributor to regional market growth.
Europe’s expansion is propelled by a strong tradition of scientific excellence, coordinated research initiatives and substantial public‑private partnership programs that prioritize precision therapeutics. The region’s regulatory harmonization simplifies cross‑border adoption of advanced chromatographic methods, while extensive biotech clusters in key economies foster intensive collaboration and skill development. Emerging focus on personalized medicine and glycoprotein therapeutics creates heightened demand for selective affinity tools. Integrated supply chains, a dense network of specialized instrument manufacturers and a commitment to sustainable laboratory practices further accelerate market uptake across the continent.
Boronate Affinity Chromatography Market in Germany benefits from a robust chemical and pharmaceutical manufacturing base, coupled with world‑class engineering expertise. The country’s strong emphasis on automation and process optimization drives the integration of high‑precision affinity technologies into routine analytical workflows. Collaborative research networks between industry giants and leading universities reinforce continuous innovation, ensuring that German manufacturers remain at the forefront of method development and application.
Boronate Affinity Chromatography Market in the United Kingdom experiences accelerated growth through vibrant biotech entrepreneurship and substantial research funding streams. The nation’s reputation for pioneering life‑science research attracts global collaborations, fostering rapid adoption of cutting‑edge affinity platforms. Strategic initiatives that link academic discoveries with commercial translation enhance the availability of specialized chromatography solutions, positioning the United Kingdom as a fast‑moving hub within the European landscape.
Boronate Affinity Chromatography Market in France is emerging alongside a growing portfolio of life‑science startups and a supportive governmental innovation agenda. Focused investment in biopharmaceutical research centers and interdisciplinary collaborations nurtures expertise in selective purification techniques. This nurturing environment encourages early adoption of affinity chromatography, gradually expanding the market presence and establishing France as a notable contributor to the broader European sector.
Asia Pacific is amplifying its role through a concerted push toward advanced biopharmaceutical development and manufacturing excellence. Governments across the region are championing strategic initiatives that fund research infrastructure and incentivize technology transfer, fostering a climate conducive to sophisticated analytical methods. The burgeoning network of contract research organizations offers cost‑effective expertise, enabling wider application of boronate affinity platforms in glycoprotein analysis and therapeutic purification. Coupled with escalating demand for high‑throughput, high‑selectivity solutions, the region’s emphasis on skill development and collaborative innovation propels its market influence and positions it as a dynamic growth engine.
Boronate Affinity Chromatography Market in Japan leverages a highly advanced manufacturing sector and a long‑standing commitment to precision science. Strong collaboration between leading pharmaceutical firms and research institutions drives rigorous method development, while a culture of continuous improvement ensures that affinity technologies are finely tuned for complex biological challenges. This environment sustains Japan’s reputation as a leader in analytical rigor and reliable market supply.
Boronate Affinity Chromatography Market in South Korea is propelled by rapid biotech expansion and proactive governmental support for life‑science innovation. The country’s focus on next‑generation therapeutics and vibrant startup ecosystem accelerates the adoption of selective affinity techniques. Integrated research platforms and close ties between academia, industry and service providers foster swift implementation of advanced chromatography solutions, reinforcing South Korea’s emerging prominence in the regional market.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Demand for Biopharma Purification
Adopting Robust Affinity Materials
High Cost of Specialized Resins
Regulatory Complexity for Novel Ligands
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global Boronate Affinity Chromatography market is shaped by intense rivalry among established chromatography manufacturers and emerging biotech firms, driving rapid product innovation and strategic collaborations. Recent M&A activity includes large life‑science companies acquiring niche resin developers to broaden their affinity‑chromatography portfolios, while partnerships with academic institutions accelerate the development of next‑generation boronate ligands for glycoprotein purification. These moves intensify competition and reinforce market expansion.
Top Player’s Company Profile
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global boronate affinity chromatography market is being propelled primarily by the growing demand for biopharma purification, as manufacturers seek highly selective platforms that preserve glycoprotein integrity, while a second driver comes from the adoption of robust affinity materials that extend column life and lower operational costs. The market’s leading segment remains boronate affinity resins, which provide the core binding matrix for both analytical and preparative workflows. North America dominates the landscape due to its dense biotech ecosystem, strong funding and early‑technology adoption. However, high cost of specialized resins acts as a restraint, limiting uptake among smaller labs and emerging firms.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 472.0 Million |
| Market size value in 2033 | USD 1016.71 Million |
| Growth Rate | 8.9% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Boronate Affinity Chromatography Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Boronate Affinity Chromatography Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Boronate Affinity Chromatography Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Boronate Affinity Chromatography Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Boronate Affinity Chromatography Market size was valued at USD 472.0 Million in 2024 and is poised to grow from USD 514.01 Million in 2025 to USD 1016.71 Million by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).
The competitive landscape of the global Boronate Affinity Chromatography market is shaped by intense rivalry among established chromatography manufacturers and emerging biotech firms, driving rapid product innovation and strategic collaborations. Recent M&A activity includes large life‑science companies acquiring niche resin developers to broaden their affinity‑chromatography portfolios, while partnerships with academic institutions accelerate the development of next‑generation boronate ligands for glycoprotein purification. These moves intensify competition and reinforce market expansion. 'Cytiva', 'Merck KGaA', 'Bio-Rad Laboratories, Inc.', 'Tosoh Corporation', 'Thermo Fisher Scientific Inc.', 'Agilent Technologies, Inc.', 'Danaher Corporation', 'Sartorius AG', 'Repligen Corporation', 'Purolite Corporation', 'Sepax Technologies, Inc.', 'GenScript Biotech Corporation', 'Kaneka Corporation', 'Avantor, Inc.', 'Biotage AB', 'YMC Co., Ltd.', 'Pall Corporation', 'Shimadzu Corporation', 'GL Sciences Inc.', 'Waters Corporation'
Manufacturers of therapeutic proteins and antibodies are increasingly seeking purification platforms that can deliver high selectivity while preserving product integrity. Boronate affinity chromatography offers precise binding to cis‑diol containing biomolecules, reducing downstream processing steps. This capability aligns with the industry’s emphasis on speed to market and cost efficiency, encouraging adoption across research and commercial scales. Consequently, the expanding pipeline of biologics directly fuels demand for this technology, positioning it as a preferred choice for critical purification challenges. It is valuable in early‑stage development and large‑scale manufacturing environments.
Protein Therapeutics Expansion: Demand for high‑purity monoclonal antibodies and emerging glyco‑engineered proteins is driving adoption of boronate affinity chromatography as a selective tool for glycan capture, enabling streamlined downstream processing. Manufacturers are integrating these resins into continuous purification platforms to reduce batch variability and improve product consistency. The ability to target specific carbohydrate motifs aligns with the industry’s focus on reducing development timelines, enhancing process robustness, and meeting stringent quality expectations for next‑generation biologics through innovation while supporting regulatory compliance and market differentiation.
Why does North America Dominate the Global Boronate Affinity Chromatography Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
